EMD-27921

Single-particle
3.1 Å
EMD-27921
3D View Gallery
Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27921

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8e6k summary report (pdf.gz) Map-8e6k FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)

EMD-27921

Single-particle
3.1 Å
EMD-27921
3D View Gallery
Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus (A/Brevig Mission/1/1918(H1N1)), Homo sapiens
Sample: 2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)
Fitted models: 8e6k

Deposition Authors: Turner HL, Ozorowski G, Ward AB
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Hansen L, McMahon M, Turner HL, Zhu X, Turner JS, Ozorowski G, Stadlbauer D, Vahokoski J, Schmitz AJ, Rizk AA, Alsoussi WB, Strohmeier S, Yu W, Choreno-Parra JA, Jimenez-Alvarez L, Cruz-Lagunas A, Zuniga J, Mudd PA, Cox RJ, Wilson IA, Ward AB, Ellebedy AH, Krammer F
(2023) Immunity , 56 , 1927 - 1938.e8
PUBMED: 37506693
DOI: doi:10.1016/j.immuni.2023.07.004
ISSN: 1074-7613
ASTM: IUNIEH